Clinical Trials
Clario and XingImaging expand partnership to deliver PET imaging clinical trials in China
Clario, formerly ERT and Bioclinica, and XingImaging joined forces in 2018 to support multi-center clinical trials requiring PET for eligibility and drug e...
January 12, 2022 | News
CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA
With the RMAT designation, CT041 enjoys all the benefits of Fast Track and Breakthrough Therapy designations including early and intensive FDA guidance on ...
January 11, 2022 | News
Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials
Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction ...
January 10, 2022 | News
Nuance Pharma acquires Sino Health
Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, tod...
January 07, 2022 | News
Calyxt Announces Pilot BioFactory™ Production System Now Operational
"I am proud of the effort our team and suppliers made to achieve this milestone on schedule, as it marks an important step in the scaling of our production...
January 07, 2022 | News
Study highlights Antengene's complementary focus on diseases with a higher prevalence in China
Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and ...
January 03, 2022 | News
Ascletis Expands Ritonavir Oral Tablet Production
Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...
January 03, 2022 | News
Top Six Global Biopharmaceutical Stories and Trends of 2021
BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the ...
December 17, 2021 | News
Noorik Biopharmaceuticals announces contract for ambrisentan treatment of COVID-19
Noorik Biopharmaceuticals Ltd. ("Noorik"), a clinical-stage biopharmaceutical company repurposing micro-dose ambrisentan for the treatment of kidney, liver...
December 16, 2021 | News
Everest Medicines to treat Triple-Negative Breast Cancer in South Korea
Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...
December 15, 2021 | News
WuXi AppTec Receives 2021 Global Customer Value Leadership Award
The Frost & Sullivan Best Practices Awards recognize companies at the forefront of their industries that consistently demonstrate leadership in innovat...
December 09, 2021 | News
Clinical Ink Acquires Digital Artefacts
Clinical Ink — a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct — ...
November 08, 2021 | News
China to Position Taizhou as a famous Chinese Medical City
It will build a platform for international exchanges and cooperation in the pharmaceutical and general health industries to further gather innovative...
November 05, 2021 | News
BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography de...
November 04, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
